Palatin Technologies, Inc. , a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system, today announced ...
Advancing differentiated MC4R-based obesity programs into clinical development Melanocortin-based obesity therapies targeting rare MC4R pathway disorders with a primary ...
S&P Global Inc. rated a Strong Buy with high-margin and capital-light business, generates cash for dividends, buybacks and M&A. Read more on SPGI stock here.
Quote: "We have seen a significant migration of mortgage origination and servicing out of the banking sector," Fed Vice Chair for Supervision Michelle Bowman told an American Bankers Association event ...
Robust revenue growth of +3.3% like-for-like1 in 2025, accelerating in Q4 (+8.1%)Cement business stabilized in France, recovery in Switzerland, and strong growth in the Mediterranean regionEBITDA of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results